Mustang Research Development from 2010 to 2026

MBIO Stock  USD 0.91  0.01  1.11%   
Mustang Bio Research Development yearly trend continues to be very stable with very little volatility. Research Development is likely to drop to about 9.2 M. During the period from 2010 to 2026, Mustang Bio Research Development quarterly data regression pattern had sample variance of 398.9 T and median of  9,196,665. View All Fundamentals
 
Research Development  
First Reported
2015-06-30
Previous Quarter
98 K
Current Value
333 K
Quarterly Volatility
5.8 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Mustang Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mustang Bio's main balance sheet or income statement drivers, such as Interest Expense of 5.5 K, Selling General Administrative of 8.5 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.009 or Days Sales Outstanding of 0.0. Mustang financial statements analysis is a perfect complement when working with Mustang Bio Valuation or Volatility modules.
  
Build AI portfolio with Mustang Stock
Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.
Evaluating Mustang Bio's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Mustang Bio's fundamental strength.

Latest Mustang Bio's Research Development Growth Pattern

Below is the plot of the Research Development of Mustang Bio over the last few years. It is Mustang Bio's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mustang Bio's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Mustang Research Development Regression Statistics

Arithmetic Mean20,209,021
Geometric Mean12,239,398
Coefficient Of Variation98.83
Mean Deviation16,703,982
Median9,196,665
Standard Deviation19,972,518
Sample Variance398.9T
Range59.9M
R-Value0.47
Mean Square Error330.9T
R-Squared0.22
Significance0.06
Slope1,864,706
Total Sum of Squares6382.4T

Mustang Research Development History

20269.2 M
20259.7 M
20248.4 M
202339.2 M
202263.9 M
202153.5 M
202045.6 M

About Mustang Bio Financial Statements

Mustang Bio investors utilize fundamental indicators, such as Research Development, to predict how Mustang Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development9.7 M9.2 M

Pair Trading with Mustang Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mustang Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Mustang Stock

  0.72DWTX Dogwood TherapeuticsPairCorr
  0.8EDIT Editas Medicine Earnings Call This WeekPairCorr

Moving against Mustang Stock

  0.6IMMP Immutep Ltd ADRPairCorr
  0.58ENGN enGene Holdings CommonPairCorr
  0.57DSGN Design TherapeuticsPairCorr
  0.33KYTX Kyverna TherapeuticsPairCorr
The ability to find closely correlated positions to Mustang Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mustang Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mustang Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mustang Bio to buy it.
The correlation of Mustang Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mustang Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mustang Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mustang Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Mustang Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mustang Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mustang Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mustang Bio Stock:
Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Will Biotechnology sector continue expanding? Could Mustang diversify its offerings? Factors like these will boost the valuation of Mustang Bio. Expected growth trajectory for Mustang significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mustang Bio data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(6.71)
Revenue Per Share
(0)
Return On Assets
(0.08)
Return On Equity
(4.19)
Mustang Bio's market price often diverges from its book value, the accounting figure shown on Mustang's balance sheet. Smart investors calculate Mustang Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Mustang Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Mustang Bio's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mustang Bio represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.